The issue of the availability of medicines during a pandemic has become especially acute. The domestic pharmaceutical industry, faced with restrictions caused by the spread of COVID-19, nevertheless continued to provide the population with medicines and even, if necessary, increased the pace of production, maintaining the uninterrupted supply of pharmaceutical products. A number of bills […]
Press-Center
Speaking at the scientific conference «Ensuring health preservation: new challenges and threats to drug safety» held in Moscow, ARPM General Director Victor Dmitriev drew attention to the components of the development of the local pharmaceutical industry. Speaking about preferences for local companies, he noted that “support should not be turned into an overprotection, and the […]
Major pharmaceutical companies, business associations and experts from the EU and the EAEU discussed a common position on the formation of a single pharmaceutical market from Lisbon to Vladivostok, and also welcomed the accession of the Association of Russian Pharmaceutical Manufacturers to the Lisbon-Vladivostok Initiative Moscow, April 28, 2021. The first meeting of the expert […]
ARPM is against the “second is extra” initiative and for reasonable amendments to patent legislation
On April 8, a strategic session of the Association of Russian Pharmaceutical Manufacturers, uniting the leaders of the local pharmaceutical industry, took place. During the session, the main goals and objectives of the Association for the near future were identified, among which: activities to improve the pricing system for medicines, adjusting regulations aimed at providing […]
On April 1, 2021, Sun Pharmaceutical Industries Limited (India), another company that localized production in the Russian Federation, joined ARPM. Sun Pharma is focused on the Russian market and deep localization of production. PJSC «Biosintez» is the company’s production site in the Penza region, and today it produces more than 180 drugs, 70% of which […]
Recall that the Association of Russian Pharmaceutical Manufacturers as early as February 1, 2021, turned to the Ministry of Industry and Trade following the results of a round table held on January 27 at the RF CCI with a proposal to amend the standard form of an agreement for the provision of labeling services to […]
For two days, the platforms of Komsomolskaya Pravda and the Eurasian Pharmaceutical Forum became centers for discussion of the most acute and relevant topic today — drug labeling. The participants of the discussion raised issues related to technical nuances, adjusting the system during the transition period, correcting errors and interacting with the DMM (Drug Movement […]
JSC «Valenta Pharm», which stood at the origins of the foundation of the Association of Russian Pharmaceutical Manufacturers (ARPM), is renewing its membership in the Association since 2021. Since 2002, when ARPM was founded, there have been many changes in the Russian pharmaceutical market — the market itself has grown significantly, new Russian enterprises have […]
The Interfactional Working Group on Improving the Legislation in the Sphere of Medicinal Provision of Citizens and the Circulation of Medicines of the State Duma supported the proposals of the participants of the meeting, which took place online, on the need to amend by-laws regulating the functioning of the DMM system. In particular, they talked […]
This exact aphorism of the moderator of the panel session, Alexei Kuzmin, became the leitmotif of the entire conference “Mandatory Labeling of Medicinal Products: Preparation and Implementation”, which took place on 26 January in an online format. Participants of all links in the distribution chain of various product groups shared their experience, told colleagues who […]